Literature DB >> 23889562

Pharmacokinetics, pharmacodynamics and local tolerance at injection site of marbofloxacin administered by regional intravenous limb perfusion in standing horses.

Elodie Lallemand1, Pierre Trencart, Carine Tahier, Frederic Dron, Angelique Paulin, Caroline Tessier.   

Abstract

OBJECTIVE: To evaluate pharmacokinetic-pharmacodynamic variables and local tolerance at injection-site of marbofloxacin administered via regional intravenous limb perfusion (RIVLP) in standing horses. ANIMALS: Adult horses (n = 6).
METHODS: RIVLP were performed with rubber tourniquets applied to the forelimbs of standing sedated horses. Marbofloxacin (0.67 mg/kg) was randomly injected in 1 forelimb, with the contralateral limb serving as a control (0.9% NaCl solution). Samples of jugular blood and synovial fluid from the radiocarpal joint of the marbofloxacin-perfused limb were collected before and at intervals after RIVLP for determination of drug concentrations. All injection sites were evaluated before, 24 and 48 hours after RIVLP by means of ultrasonographic examination, circumferential measurements and subjective visible inflammation scores by veterinarians unaware of treatment received.
RESULTS: No adverse effects associated with the technique or antibiotic were observed. High marbofloxacin concentrations were obtained in the synovial fluid, AUCINF was significantly higher in synovial fluid than in plasma (78.64 ± 49.41 and 2.85 ± 0.60 µg h/mL respectively, P = .028). The efficacy indices, AUC0-24 /MIC90 and Cmaxobs/MIC90 , predicted a favorable outcome in the treatment of synovial fluid infections caused by enterobacteriaceae and Staphylococcus aureus. After RIVLP, there was no statistically significant difference between marbofloxacin-injected and control limbs for lameness, visual inflammation score, limb circumference, and ultrasonographic appearance of the veins. Marbofloxacin injected limbs had a significantly greater subcutaneous thickness, compared with control limbs.
CONCLUSIONS: These data suggest that RIVLP of marbofloxacin (0.67 mg/kg) could be a safe and effective method for treatment of infections of the distal portion of the limb for susceptible organisms. © Copyright 2013 by The American College of Veterinary Surgeons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23889562     DOI: 10.1111/j.1532-950X.2013.12030.x

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  2 in total

1.  Effects of regional limb perfusion technique on concentrations of antibiotic achieved at the target site: A meta-analysis.

Authors:  Laurel E Redding; Elizabeth J Elzer; Kyla F Ortved
Journal:  PLoS One       Date:  2022-04-01       Impact factor: 3.240

2.  Pharmacokinetics of marbofloxacin administered via intravenous regional limb perfusion in dairy cows: evaluation of two different tourniquets.

Authors:  Gianluca Celani; Serena Maria Rita Tulini; Camilla Montesano; Daniela Zezza; Manuel Sergi; Vincenzo Varasano; Carlo Maria Mortellaro; Dario Compagnone; Michele Amorena; Lucio Petrizzi
Journal:  Vet Rec Open       Date:  2017-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.